Understanding Obesity: From Diagnosis to Modern Treatment

Table of Contents

• Key Points
• Why This Research Matters
• The Global Burden of Obesity: A Worldwide Health Crisis
• Health Risks: What Obesity Does to the Body
• Treatment Options: Why Bariatric Surgery Is the Standard of Care
• How Surgical Approaches Are Evolving
• Obesity and COVID-19: A Life-Saving Connection
• A Call for New Research and Innovation
• Clinical Implications: What This Means for Patients
• Recommendations: Actionable Steps for Patients
• Study Limitations: What This Article Cannot Prove
• Frequently Asked Questions
• Source Information

Key Points

• Obesity is a chronic disease affecting 13% of adults globally, defined by a BMI of 30 or higher.
• Bariatric surgery is the standard treatment, offering lasting weight loss and reducing type 2 diabetes, hypertension, and sleep apnea.
• Obesity increases risk for diabetes, high blood pressure, fatty liver disease, certain cancers, joint degeneration, and other serious conditions.
• During COVID-19, obesity was an independent risk factor for death, hospitalization, ICU admission, and mechanical ventilation.
• Bariatric techniques are evolving toward safer laparoscopic and robotic approaches, with metabolic surgery expanding treatment to lower-BMI patients.

Why This Research Matters

Obesity is no longer viewed as a simple lifestyle issue or a matter of willpower. Leading medical experts now classify it as a chronic disease — a long-term condition that requires ongoing medical management, just like diabetes or high blood pressure. This distinction is critical for patients, because it changes how obesity is diagnosed, treated, and covered by healthcare systems.

Dr. Tigran Poghosyan, a surgeon at the Department of Digestive, Oncologic and Bariatric Surgery at AP-HP Hôpital Européen Georges Pompidou and a faculty member at Paris Descartes University in France, authored this call for research in the Journal of Clinical Medicine. His message underscores that obesity's impact extends far beyond weight itself, affecting nearly every system in the body. He emphasizes that the negative health consequences of obesity are severe and wide-ranging, and that effective treatment is both possible and necessary.

This article translates that medical call-to-action into practical information for patients and families affected by obesity — explaining how the disease is measured, why it's dangerous, and what modern treatments offer.

The Global Burden of Obesity: A Worldwide Health Crisis

The numbers behind obesity are staggering. According to the World Health Organization (WHO), the statistics are as follows:

• 39% of adults worldwide are overweight — defined by a body mass index (BMI) of 25 to 29.9, a measurement that relates weight to height
• 13% of adults worldwide are obese — defined by a BMI of 30 or higher

To put that in perspective: out of every 100 adults you encounter, roughly 39 carry excess weight, and about 13 live with clinical obesity. That means obesity affects hundreds of millions of people across every region, income level, and age group. This is not a rare condition or a niche medical concern — it is one of the most common chronic diseases on Earth.

These figures also highlight an important distinction. While "overweight" is a cause for concern and early intervention, "obesity" represents a more serious stage of the disease, with a proportionally higher risk of complications. Understanding this spectrum helps patients recognize where they stand and when to seek medical advice.

Health Risks: What Obesity Does to the Body

Obesity does not exist in isolation. It acts as a known risk factor for a long list of serious medical conditions — often called comorbidities, meaning diseases that occur alongside and because of obesity. Dr. Poghosyan's message specifically highlights the following conditions:

• Type 2 diabetes — a metabolic disorder in which the body becomes resistant to insulin, leading to dangerously high blood sugar levels. Obesity is the single strongest driver of this condition.
• High blood pressure (hypertension) — persistent elevation of pressure in the arteries, which forces the heart to work harder and increases the risk of heart attack and stroke.
• Metabolic syndrome — a cluster of conditions that occur together, including increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol levels. Having metabolic syndrome roughly doubles the risk of heart disease.
• Sleep apnea — a disorder in which breathing repeatedly stops and starts during sleep, causing poor rest, daytime fatigue, and increased cardiovascular strain.
• Fatty liver disease — an accumulation of fat in liver cells that can progress to inflammation, scarring (cirrhosis), and even liver failure. Also known as non-alcoholic fatty liver disease (NAFLD), it is now the most common liver disorder in the world.

But this list is not complete. Obesity is also associated with certain cancers, joint degeneration (osteoarthritis), kidney disease, depression, and infertility. The exact mechanisms are complex, involving inflammation, hormonal changes, and mechanical stress on the body.

For patients, this means obesity should not be viewed as a cosmetic concern. It is a medical condition with measurable, serious consequences that can shorten life expectancy by many years if left untreated.

Treatment Options: Why Bariatric Surgery Is the Standard of Care

Given the severity of obesity-related complications, effective treatment is essential. Dr. Poghosyan's message is clear: currently, bariatric surgery is the standard treatment for obesity. This is not a fringe opinion — it reflects years of clinical evidence showing that surgical intervention produces outcomes that medical therapy alone often cannot achieve.

Bariatric surgery — commonly called weight-loss surgery — includes several procedures that work by altering the digestive system to promote weight loss. The most common types include:

1. Gastric bypass (Roux-en-Y) — the stomach is divided into a small pouch, and the small intestine is rerouted to connect to it, reducing how much food you can eat and how many calories are absorbed.
2. Sleeve gastrectomy (gastric sleeve) — about 80% of the stomach is removed, leaving a narrow tube-shaped stomach that holds much less food and produces fewer hunger hormones.
3. Adjustable gastric banding — a band is placed around the upper stomach to create a small pouch, though this procedure is less commonly used today.
4. Biliopancreatic diversion with duodenal switch — a more complex procedure that both restricts food intake and reduces absorption, typically reserved for patients with severe obesity.

What does the evidence show about these procedures? According to the research highlighted by Dr. Poghosyan, bariatric surgery results in:

• Significant and lasting weight loss — patients maintain substantial weight reduction for years, not just months.
• Reduction of comorbidities — many patients experience complete resolution or major improvement of type 2 diabetes, high blood pressure, and sleep apnea after surgery. In some studies, diabetes remission rates exceed 70%.

The role of bariatric surgery goes beyond the scale. When a patient's diabetes disappears or their blood pressure normalizes, the benefits cascade: fewer medications, less cardiovascular strain, reduced risk of complications, and improved quality of life. The surgery buys health, not just thinness.

How Surgical Approaches Are Evolving

One of the central themes of Dr. Poghosyan's message is that the field of bariatric surgery is not static. He notes that some interventions have disappeared, while others, even more efficient and secure, have appeared.

This evolution matters for patients because it means the procedure you may have read about ten years ago might not be what is performed today. For example, certain older techniques that carried higher complication rates have been largely abandoned. In their place, minimally invasive approaches — such as laparoscopic and robotic surgery — have made recovery faster and safer. Newer procedures are continually being refined to maximize weight loss, preserve nutritional health, and minimize side effects such as dumping syndrome or vitamin deficiencies.

The field has also expanded beyond purely "restrictive" procedures. Metabolic surgery — a newer term used in the same breath as bariatric surgery — refers to operations designed specifically to treat metabolic diseases like type 2 diabetes, sometimes in patients with lower BMIs. This research area is rapidly expanding and may eventually offer surgical solutions to more patients who do not meet traditional obesity surgery criteria.

For patients exploring options, this means asking your surgeon about the current best-practice procedures — not assuming that what worked for a family member two decades ago is still the gold standard today.

Obesity and COVID-19: A Life-Saving Connection

Dr. Poghosyan describes 2020–2021 as a period of "collective awakening" regarding obesity — and the catalyst was the COVID-19 pandemic. The pandemic highlighted that obesity was an independent factor of mortality, causing devastation in the population suffering from obesity.

What does "independent factor of mortality" mean in plain language? It means that even after accounting for other risk factors such as age, smoking, or other chronic illnesses, having obesity on its own increased a person's risk of dying from COVID-19. The scientific evidence during the pandemic consistently showed that patients with obesity were more likely to be hospitalized, require intensive care (ICU) admission, need mechanical ventilation, and die from the virus.

Several mechanisms explain this vulnerability, including:

• Impaired immune response due to chronic low-grade inflammation associated with excess fat tissue
• Reduced lung function and lung capacity, made worse by abdominal obesity pressing on the diaphragm
• Higher rates of blood clotting (thrombosis) in patients with obesity
• Difficulty with oxygenation and mechanical ventilation in critical care settings

Dr. Poghosyan's words are a call to action: "This challenge needs to be faced together" through clinical and scientific studies reported by different teams through publications. The pandemic demonstrated, with tragic clarity, that obesity is not a cosmetic issue — it is a life-and-death vulnerability. For patients who were previously undecided about obesity treatment, the pandemic added a powerful reason to act.

A Call for New Research and Innovation

This article originated as an editorial invitation from the Journal of Clinical Medicine (JCM), an open-access journal published by MDPI. Dr. Poghosyan, serving as the Collection Editor, invited researchers worldwide to submit work in the field of bariatric and metabolic surgery and nutrition, focusing on all aspects — challenges, trends, and prospects — that could improve daily clinical practices.

The journal itself has notable credentials that underscore the scientific reliability of the research published there:

• Impact Factor: 4.964 — a measure of how often articles in the journal are cited in other research.
• Open Access — articles are free for readers, with article processing charges (APC) paid by authors or their institutions.
• Indexed in Scopus, SCIE (Web of Science), PubMed, PMC, Embase, and CAPlus/SciFinder.
• JCR Rank: Q2 (Medicine, General & Internal); CiteScore Rank: Q1 (General Medicine).

The editorial team is led by Dr. Emmanuel Andrès (Department of Internal Medicine, University Hospital of Strasbourg, France) and Prof. Dr. Michael G. Hennerici (Department of Neurology, Universitätsklinikum Mannheim, Germany). As they note in their message, there has been an explosion of gene- and target-based research in clinical medicine, and the journal is dedicated to publishing cutting-edge, peer-reviewed articles relevant to both primary care physicians and specialists.

For patients, this context matters because it demonstrates that the information about obesity and its treatments is being rigorously validated — not by a single opinion, but by a scientific community engaged in ongoing, peer-reviewed research.

Clinical Implications: What This Means for Patients

Several practical takeaways emerge from this article for anyone living with obesity or caring for someone who is:

First, obesity deserves serious medical attention. If you have a BMI of 30 or above, this is not a vanity issue. It is a chronic disease that should be discussed with a healthcare provider who can assess your individual risk factors and explore treatment options.

Second, bariatric surgery is the most effective treatment available. While lifestyle changes — diet, exercise, and behavioral therapy — remain foundational, the evidence overwhelmingly shows that surgery produces the most significant and durable weight loss, along with substantial improvement in diabetes, hypertension, sleep apnea, and other weight-related conditions. For patients with severe obesity (BMI 35 or higher, or BMI 30+ with comorbidities), surgery should be a seriously considered option, not a last resort.

Third, the field is evolving, and so should your expectations. Modern procedures are safer and more effective than those of the past. If fear of complications has kept you from exploring surgery, it's worth learning about current techniques, which are typically performed laparoscopically with shorter hospital stays and faster recovery times.

Fourth, the link between obesity and COVID-19 is a wake-up call. The pandemic demonstrated that obesity increases the risk of death from infectious diseases. Treating obesity is one of the most effective ways to build resilience against future health threats.

Finally, the invitation for ongoing research signals hope. Scientists are actively studying new surgical techniques, nutritional approaches, and metabolic interventions. This means the treatment landscape for obesity will likely improve even further in the coming years.

Recommendations: Actionable Steps for Patients

If you are living with obesity, the information in this article translates into concrete steps you can take today:

1. Know your numbers. Calculate your BMI and be aware of your waist circumference, blood pressure, blood sugar, and cholesterol levels. These measurements help determine whether obesity is affecting your health.
2. Have a frank conversation with your doctor. Ask whether your obesity should be treated as a chronic disease and what treatment options are appropriate for your stage of the condition.
3. Explore comprehensive treatment programs. Look for programs that offer a combination of nutrition counseling, physical activity guidance, behavioral therapy, and, when appropriate, weight-loss medications or surgical consultation.
4. Do not delay. Waiting allows obesity-related complications to develop. Early intervention, even before you reach the most severe stages of obesity, produces better outcomes.
5. If considering surgery, choose an accredited center. A multidisciplinary bariatric program with experienced surgeons, nutritionists, and psychologists offers the best chance of a successful outcome and long-term follow-up.
6. Stay informed about new research. The field of metabolic surgery and nutrition is advancing. What was considered impossible in obesity treatment a decade ago is now routine. Being an informed patient empowers you to make the best decisions with your healthcare team.

Study Limitations: What This Article Cannot Prove

It is important to be transparent about what this source is — and what it is not. This article originated as a call for research submissions and a collection editor's introduction, not as a clinical trial report or a systematic review of outcomes. Therefore, it does not contain its own patient data, statistical analyses, or measured results. The statistics cited (39% overweight, 13% obese) come from the World Health Organization, and the claims about bariatric surgery effectiveness reflect widely established clinical consensus rather than new data from this specific publication.

The source also does not discuss non-surgical treatments in detail, such as newer anti-obesity medications that have emerged recently. This means patients should understand that while bariatric surgery is described here as the "standard" treatment, it is not the only treatment, and medication options may be appropriate for some patients.

Finally, because the article focuses on the European context (specifically the French healthcare system), some statistics and treatment availability may differ in other countries. Patients should consult local medical professionals for region-specific guidance.

Frequently Asked Questions

How are overweight and obesity defined?

According to the World Health Organization, overweight is defined as a body mass index (BMI) of 25 to 29.9, while obesity is a BMI of 30 or higher. BMI relates weight to height. Obesity is considered a chronic disease, not a cosmetic issue, and affects about 13% of adults worldwide.

Why is bariatric surgery considered the standard treatment for obesity?

Bariatric surgery is currently described as the standard treatment for obesity because clinical evidence shows it produces significant and lasting weight loss, often for years. It also reduces related health problems: many patients see major improvement or complete resolution of type 2 diabetes, high blood pressure, and sleep apnea. In some studies, diabetes remission rates exceed 70%.

What health conditions is obesity linked to?

Obesity increases the risk of type 2 diabetes, high blood pressure, metabolic syndrome, sleep apnea, and fatty liver disease. It is also associated with certain cancers, joint degeneration, kidney disease, depression, and infertility. During the COVID-19 pandemic, obesity was shown to be an independent risk factor for death from the virus.

What are the most common types of bariatric surgery?

Common bariatric surgery procedures include gastric bypass, which divides the stomach and reroutes the small intestine; sleeve gastrectomy, which removes about 80% of the stomach; adjustable gastric banding, which places a band around the upper stomach; and biliopancreatic diversion with duodenal switch, a more complex procedure that restricts food intake and reduces absorption.

How is bariatric surgery evolving?

The field is changing: some older techniques with higher complication rates have been abandoned, while newer, more efficient and secure procedures have appeared. Minimally invasive laparoscopic and robotic approaches now offer faster recovery and greater safety. The term metabolic surgery refers to operations designed to treat type 2 diabetes, sometimes in patients with lower BMIs.

What did COVID-19 reveal about obesity?

COVID-19 highlighted obesity as an independent factor of mortality. Even after accounting for age, smoking, or other chronic illnesses, having obesity on its own increased the risk of dying from the virus. Patients with obesity were more likely to be hospitalized, need intensive care, require mechanical ventilation, and die from COVID-19.

What steps can a person with obesity take today?

Know your numbers: calculate your BMI and check waist circumference, blood pressure, blood sugar, and cholesterol. Have a frank discussion with your doctor about whether to treat obesity as a chronic disease. Explore programs combining nutrition, physical activity, behavioral therapy, and possibly medications or surgery. Do not delay, as early intervention leads to better outcomes.

Can a second opinion help me decide between bariatric surgery and non-surgical options for obesity?

Yes. Bariatric surgery is the standard treatment for obesity, but it is not the only option. A second opinion can confirm whether surgery is appropriate for your BMI and health status, and it can help you weigh less invasive alternatives, including newer anti-obesity medications. Surgery often leads to lasting weight loss and improves conditions such as type 2 diabetes, high blood pressure, and sleep apnea, but individual responses vary. Because the field is evolving, an independent expert can clarify current procedure risks and benefits. Diagnostic Detectives Network provides independent expert second opinions.

Source Information

Original article title: Pogossyan HEGP Obesity- From Diagnosis to Treatment

Collection Editor: Dr. Tigran Poghosyan, Department of Digestive, Oncologic and Bariatric Surgery, AP-HP Hôpital Européen Georges Pompidou, and UFR Paris Descartes, Université de Paris, 20 Rue Leblanc, 75015 Paris, France.

Editors-in-Chief: Dr. Emmanuel Andrès (Department of Internal Medicine, University Hospital of Strasbourg, 67000 Strasbourg, France) and Prof. Dr. Michael G. Hennerici (Department of Neurology, Universitätsklinikum Mannheim, Ruprecht-Karls-Universität Heidelberg, Mannheim, Germany).

Journal details: Impact Factor 4.964; indexed in Scopus, SCIE (Web of Science), PubMed, PMC, Embase, CAPlus/SciFinder; JCR Q2 (Medicine, General & Internal); CiteScore Q1 (General Medicine). Contact: MDPI, St. Alban-Anlage 66, 4052 Basel, Switzerland.

Note: This patient-friendly article is based on peer-reviewed research and editorial content published in the Journal of Clinical Medicine. It is intended for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional about your individual treatment options.